Summary
The transcriptional activity of the c-myc proto-oncogene was examined in 25 primary human colorectal carcinomas and their corresponding normal mucosae. The purpose was to determine whether the elevated levels of c-myc expression, frequently detected in this type of tumor, might be the consequence of alterations in the cell growth rate or the effect of a real transcriptional deregulation of the gene. In about 44% of the tumors the elevated c-myc expression was consequent to the enhanced growth rate of the neoplastic tissue, as estimated by the expression of the S-phase-specific histone H3 gene. In the other 56%, c-myc overexpression did not entirely depend on the proliferative activity of the neoplastic population. In this latter group, c-myc deregulation did not reside in structural modifications of the putative regulatory regions of the gene. Therefore, c-myc overexpression, at least in a subset of colorectal cancer, seems to be consequent to alterations in transregulative phenomena exerted on the c-myc gene by other genetic loci.
Similar content being viewed by others
References
Adams JM, Harris AW, Pinkert CA, Corcoran LM, Alexander WS, Cory S, Palmiter RD, Brinster RL (1985) The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318:533–538
Alitalo K, Schwab M, Lin CC, Varmus HE, Bishop JM (1983) Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma. Proc Natl Acad Sci USA 80:1707–1711
Astler VB, Coller FA (1954) The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 139:846–851
Astrin SM, Costanzi C (1989) The molecular genetics of colon cancer. Semin Oncol 16:138–147
Baserga R (1981) The cell cycle. N Engl J Med 304:453–459
Bentley DL, Groudine M (1986) A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells. Nature 321:702–706
Bentley DL, Groudine M (1988) Sequence requirements for premature termination of transcription in the human c-myc gene. Cell 53:245–256
Bishop JM (1983) Cellular oncogenes and retroviruses. Annu Rev Biochem 52:301–354
Calabretta B, Kaczmarek L, Ming PL, Au F, Ming S (1985) Expression of c-myc and other cell-cycle-dependent genes in human colon neoplasia. Cancer Res 45:6000–6004
Campisi J, Gray HE, Pardee AB, Dean M, Sonenshein GE (1984) Cell cycle control of c-myc but not c-ras expression is lost following chemical transformation. Cell 36:244–247
Cesarman E, Dalla Favera R, Bentley D, Groudine M (1987) Mutations in the first exon are associated with altered transcription of c-myc in Burkitt Lymphoma. Science 238:1272–1275
Chung J, Sinn E, Reed RR, Leder P (1986) Trans-acting elements modulate expression of the human c-myc gene in Burkitt lymphoma cells. Proc Natl Acad Sci USA 83:7918–7922
Cole MD (1985) Regulation and activation of c-myc. Nature 318:510–511
Cooper GM (1982) Cellular transforming genes. Science 218:801–806
Cox RA (1968) The use of guanidine chloride in the isolation of nucleic acid. Meth Enzymol 12:120–129
Del Senno L, Degli Uberti E, Bernardi F, Marchetti G, Perrotta C, Gambari R, Barbieri R, Buzzoni D, Pansini G, Conconi F (1987) c-myc oncogene alterations in human thyroid carcinomas. Cancer Detect Prev 10:159–166
Dolcetti R, De Re V, Viel A, Pistello M, Tavian M, Boiocchi M (1988) Nuclear oncogene amplification or rearrangement is not involved in human colorectal malignancies. Eur J Cancer Clin Oncol 24:1321–1328
Donner P, Greiser-Wilke I, Moelling K (1982) Nuclear localization and DNA binding of the transforming gene product of avian myelocytomatosis virus. Nature 296:262–265
Erisman MD, Rothberg PG, Diehl RE, Clarence CM, Spandorfer JM, Astrin SM (1985) Deregulation of c-myc gene expression in human colon carcinoma is not accompanied by amplification or rearrangement of the gene. Mol Cell Biol 5:1969–1976
Erisman MD, Scott JK, Astrin SM (1989) Evidence that the familial adenomatous polyposis gene is involved in a subset of colon cancers with a complementable defect in c-myc regulation. Proc Natl Acad Sci USA 86:4264–4268
Feinberg AP, Gehrke CW, Kuo KC, Ehrlich M (1988) Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res 48:1159–1161
Ferrari S, Narni F, Mars W, Kaczmarek L, Venturelli D, Anderson B, Calabretta B (1986) Expression of growth-regulated genes in human acute leukemias. Cancer Res 46:5162–5166
Goelz SE, Vogelstein B, Hamilton SR, Feinberg AP (1985) Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 228:187–190
Goyette M, Petropoulos CJ, Shank PR, Fausto N (1984) Regulated transcription of c-Ki-ras and c-myc during compensatory growth of rat liver. Mol Cell Biol 4:1493–1498
Hann SR, Eisenman RN (1984) Protein encoded by the human c-myc oncogene: differential expression in neoplastic cells. Mol Cell Biol 4:2486–2497
Hann SR, Thompson CB, Eisenman RN (1985) c-myc oncogene protein synthesis is independent of the cell cycle in human and avian cells. Nature 314:366–369
Kelly K, Cochran BH, Stiles CD, Leder P (1983) Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35:603–610
Makino R, Hayashi K, Sugimura T (1984) c-myc transcript is induced in rat liver at a very early stage of regeneration or by cycloheximide treatment. Nature 310:697–698
Maniatis T, Fritsh EF, Sambrook J (1982) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
Meltzer PS, Shadle KM, Durie BGM (1988) Characterization of recurrent alterations of c-myc in multiple myeloma. Proc Am Soc Clin Oncol Annu Meet 7:52
Morse B, South VJ, Rothberg PG, Astrin SM (1989) Somatic mutation and transcriptional deregulation of myc in endemic Burkitt's lymphoma disease: heptamer-nonamer recognition mistakes? Mol Cell Biol 9:74–82
Nambu S, Inoue K, Sasaki H (1987) Site-specific hypomethylation of the c-myc oncogene in human hepatocellular carcinoma. Jpn J Cancer Res 78:695–704
Pelicci PG, Knowles DM, Magrath I, Dalla Favera P (1986) Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma. Proc Natl Acad Sci USA 83:2984–2988
Ponte P, Gunning P, Blau H, Kedes L (1983) Human actin gene are single copy forα-skeletal andα-cardiac actin but multicopy forβ and γ-cytoskeletal genes: 3′ untranslated regions are isotype specific but are conserved in evolution. Mol Cell Biol 3:1783–1791
Rabbitts TH, Forster A, Stinson MA, Rabbits PH (1985) Truncation of exon 1 from the c-myc gene results inprolonged c-myc mRNA stability. EMBO J 4:3727–3733
Sierra F, Lichtler A, Marashi F, Rickles R, Van Dyke T, Clark S, Wells J, Stein G, Stein J (1982) Organization of human histone genes. Proc Natl Acad Sci USA 79:749–753
Sikora A, Chan S, Evan G, Gabra H, Markham N, Stewart J, Watson J (1987) c-myc oncogene expression in colorectal cancer. Cancer 59:1289–1295
Southern E (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98:503–517
Sugio K, Kurata S, Sasaki M, Soejima J, Sasazuki T (1988) Differential expression of c-myc gene and c-fos gene in premalignant and malignant tissues from patients with familial polyposis coli. Cancer Res 48:4855–4861
Szajnert MF, Saule S, Bornkamm GW, Wajcman H, Lenoir GM, Kaplan JC (1987) Clustered somatic mutations in and around first exon of non-rearranged c-myc in Burkitt lymphoma with t(8;22) translocation. Nucleic Acids Res 15:4553–4565
Torelli G, Venturelli D, Colo A, Zanni C, Selleri L, Moretti L, Calabretta B, Torelli U (1987) Expression of c-myb protooncogene and other cell cycle-related genes in normal and neoplastic human colonic mucosa. Cancer Res 47:5266–5269
Yunis JJ (1983) The chromosomal basis of human neoplasia. Science 221:227–236
Author information
Authors and Affiliations
Additional information
Supported by grants from the Consiglio Nazionale delle Ricerche: Progetto Finalizzato Oncologia no. 88.00537.44 and from the Associazione Italiana per la Ricerca sul Cancro
Rights and permissions
About this article
Cite this article
Viel, A., Maestro, R., Toffoli, G. et al. c-myc Overexpression is a tumor-specific phenomenon in a subset of human colorectal carcinomas. J Cancer Res Clin Oncol 116, 288–294 (1990). https://doi.org/10.1007/BF01612905
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01612905